Genetic Mutations in Herding Breeds
Herding breeds share not only remarkable intelligence and working ability but also a common genetic heritage that includes several important mutations. Understanding these shared genetic factors is essential for anyone breeding, owning, or providing veterinary care for these dogs.
This article provides an overview of the most significant genetic mutations affecting herding breeds, their inheritance patterns, and their clinical implications.
The Herding Breed Heritage
Before examining specific mutations, it is important to understand why herding breeds share so many genetic traits. Most modern herding breeds descend from common ancestral populations developed in the British Isles and continental Europe. The Collie family, in particular, forms the foundation for numerous breeds we recognize today.
This shared ancestry means that mutations present in ancestral dogs have been passed to multiple modern breeds. The MDR1 mutation, for example, likely occurred in a single dog whose descendants became Collies, Australian Shepherds, Shelties, and related breeds. The genetic bottlenecks that shaped herding breed populations further concentrated these mutations, as small effective population sizes allowed harmful alleles to reach high frequencies.
MDR1 (Multi-Drug Resistance 1)
The MDR1 mutation is the most clinically significant genetic factor in herding breeds. This mutation affects the blood-brain barrier’s ability to exclude certain drugs from the central nervous system.
Affected Breeds and Prevalence
- Collie: 70-75% carry at least one copy
- Australian Shepherd: 50-60%
- Shetland Sheepdog: 35-40%
- Old English Sheepdog: 25-30%
- Border Collie: 5-10%
Clinical Significance Dogs with two copies of the mutation (M/M) are at high risk of toxicity from ivermectin, loperamide, and numerous other medications. Even dogs with one copy (N/M) show increased sensitivity compared to normal dogs.
Testing and Management All herding breed dogs should be tested before receiving any medications on the risk list. Testing is a one-time requirement as genotype does not change. Our comprehensive DNA testing guide explains sample collection procedures and laboratory selection.
Collie Eye Anomaly (CEA)
Collie Eye Anomaly is a developmental defect affecting the choroid, retina, and sometimes the optic disc. Severity ranges from mild choroidal hypoplasia with no vision impact to severe cases with colobomas and retinal detachments causing blindness.
Affected Breeds
- Collie (Rough and Smooth)
- Shetland Sheepdog
- Border Collie
- Australian Shepherd
- Lancashire Heeler
Inheritance CEA follows autosomal recessive inheritance. Dogs need two copies of the mutation to be affected. The genetic test is highly accurate and widely available.
Breeding Recommendations Given high prevalence in some breeds, completely eliminating carriers would severely limit genetic diversity. Affected dogs should not be bred, but carriers can be paired with clear dogs to gradually reduce prevalence while maintaining diversity. For a detailed look at this condition, including clinical grading and screening protocols, visit Collie Eye Anomaly.
Progressive Retinal Atrophy (PRA)
Several forms of Progressive Retinal Atrophy affect herding breeds. PRA causes gradual vision loss, typically beginning with night blindness and progressing to complete blindness.
PRA-prcd (Progressive Rod-Cone Degeneration) This form affects Australian Shepherds, American Eskimo Dogs, and numerous other breeds. It is one of the most common forms of inherited blindness in dogs.
CEA/PRA (rcd2) This form specifically affects Collies, causing earlier-onset blindness than prcd.
Testing Different PRA mutations require different tests. Breed-specific testing panels are available to screen for the forms relevant to each breed.
Degenerative Myelopathy (DM)
Degenerative Myelopathy is a progressive neurological disease affecting the spinal cord, driven by a mutation in the SOD1 gene that shares remarkable parallels with ALS in humans. Our in-depth guide to SOD1 and degenerative myelopathy covers the molecular biology, clinical staging, and management strategies in detail. Dogs develop weakness and loss of coordination in the hind legs, eventually becoming unable to walk.
Affected Herding Breeds
- German Shepherd Dog
- Pembroke Welsh Corgi
- Cardigan Welsh Corgi
- Belgian Shepherd varieties
Clinical Course Symptoms typically appear after age seven. The disease progresses over months to years, eventually affecting the front legs and causing complete paralysis. There is no treatment.
Genetics DM is associated with a mutation in the SOD1 gene. Dogs with two copies are at risk, though not all at-risk dogs develop clinical disease. This incomplete penetrance complicates breeding decisions and may involve epigenetic factors that modulate gene expression beyond what the DNA sequence alone can predict.
Hereditary Cataracts
Multiple forms of hereditary cataracts affect herding breeds. Cataracts cause lens opacity and can lead to vision impairment or blindness.
HSF4 Cataracts in Australian Shepherds A mutation in the HSF4 gene causes cataracts in Australian Shepherds. Dogs with two copies typically develop cataracts between two and seven years of age. Dogs with one copy have increased but not certain risk.
Other Forms Different mutations cause hereditary cataracts in other herding breeds. Breed-specific testing is available for many forms.
Neuronal Ceroid Lipofuscinosis (NCL)
NCL refers to a group of inherited storage diseases affecting the nervous system. Several forms affect herding breeds.
CL in Border Collies Border Collie CL causes progressive neurological deterioration beginning around one to two years of age. Affected dogs develop vision loss, behavioral changes, and motor dysfunction.
CL in Australian Cattle Dogs
A different form affects Australian Cattle Dogs with similar progressive neurological decline.
Testing Breed-specific DNA tests identify carriers and affected dogs. Given the severity of the disease, carriers should only be bred to clear partners.
Trapped Neutrophil Syndrome (TNS)
TNS is an immune deficiency disease specifically affecting Border Collies. Affected puppies cannot effectively fight infections and typically die or are euthanized within the first few months of life.
Inheritance TNS is autosomal recessive. Carrier-to-carrier breedings produce, on average, 25% affected puppies.
Testing DNA testing accurately identifies clear dogs, carriers, and affected animals. All Border Collie breeding stock should be tested.
Cyclic Neutropenia (Gray Collie Syndrome)
This condition affects only Collies and is associated with a distinctive silver-gray coat color. Understanding how coat color genetics work in dogs helps explain the connection between this condition and the dilute coloration. Affected dogs have cyclic fluctuations in neutrophil counts, leaving them vulnerable to infections.
Recognition The unusual coat color and failure to thrive as puppies are distinctive. Most affected puppies do not survive to adulthood without intensive medical management.
Genetics Cyclic neutropenia is recessive. The gene responsible is linked to coat color dilution, which is why affected dogs have the gray coloration.
Testing Recommendations for Herding Breeds
Based on breed-specific risks, the following testing is recommended:
All Herding Breeds: MDR1
Collies: Add CEA, PRA (rcd2), Cyclic Neutropenia, DM
Australian Shepherds: Add CEA, PRA-prcd, HSF4 cataracts, DM
Border Collies: Add CEA, TNS, CL, sensory neuropathy
Shetland Sheepdogs: Add CEA, PRA, vWD Type III
German Shepherds: Add DM, degenerative myelopathy
Conclusion
The shared ancestry of herding breeds means that breeders must be aware of multiple genetic conditions. Fortunately, DNA testing is available for most significant mutations, allowing breeders to make informed decisions that prevent affected puppies while maintaining the genetic diversity essential for breed health.
Regular review of testing recommendations is important, as new mutations are discovered and new tests become available. Breed clubs and organizations like the Orthopedic Foundation for Animals maintain updated recommendations for each breed. The UC Davis Veterinary Genetics Laboratory is one of the leading facilities offering breed-specific genetic panels.
Through responsible testing and breeding practices, we can preserve the remarkable qualities of herding breeds while reducing the burden of inherited disease. As canine genomic medicine advances, new tools such as gene therapy and CRISPR editing may eventually offer the possibility of correcting these mutations at the molecular level. For questions about genetic testing for your herding breed, contact our team for personalized guidance.